Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
34 /100
MEDIUM RISK
Score updated Oct 13, 2026

VYGR — Voyager Therapeutics, Inc. Dilution Risk Tracker

Track VYGR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VYGR — Get alerts when the score changes →

As of October 13, 2026, Voyager Therapeutics, Inc. (VYGR) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. Voyager Therapeutics, Inc. has a market capitalization of $150.96M, 61.62M shares outstanding, 135 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰Cash Runway—
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for VYGR.
🔔 Track VYGR — Get forecast alerts →

Market Data

Market Cap$150.96M
Shares Outstanding61.62M
Float44.22M
Cash$116.34M
Debt$34.57M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore34/100DilutionWatch score record
Shares Outstanding61.62MVerified float table or market cache
Public Float44.22MVerified float table or market cache
Market Cap$150.96MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 15.8% shares (2026Q1 vs prior)
135 institutional holders · 39.94M shares
#1 BlackRock, Inc. 5.57M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.57M shares
#3 ARMISTICE CAPITAL, LLC 3.50M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.97M
Days to Cover6.4
% of Float9.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2018-03-14
4 INSIDER TRANSACTION 2026-02-26
4 INSIDER TRANSACTION 2026-02-26
4 INSIDER TRANSACTION 2026-02-26
4 INSIDER TRANSACTION 2026-02-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VYGR Dilution Snapshot

Voyager Therapeutics, Inc. (VYGR) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VYGR's DilutionScore has held steady at 34/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202634/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VYGR shares outstanding have increased 8.7% from 55.60M (Mar 2026) to 60.42M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 202660.42M44.22M▼ 0.08%
May 18, 202660.42M44.26M▲ 11.27%
May 10, 202660.42M39.77M▲ 2.11%
Apr 23, 202659.60M38.95M▼ 17.65%
Apr 15, 202659.60M47.30M▼ 0.03%
Mar 13, 202655.60M47.32M▲ 1.90%
Mar 11, 202655.60M46.44M▲ 7.19%
Mar 08, 202655.60M43.32M▼ 0.11%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VYGR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VYGR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VYGR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VYGR
VYGR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.